Journal of clinical lipidologyHumansMaleFemaleMiddle AgedAged
Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trial.
Venu Menon, LeAnne Bloedon, Na Li, A Michael Lincoff, Stephen J Nicholls, Heather A Powell, Steven E Nissen
Published: 202610.1016/j.jacl.2025.10.072
Abstract
BACKGROUND: Bempedoic acid is a prodrug that reduces circulating low-density lipoprotein (LDL) cholesterol levels by inhibiting the liver enzyme adenosine triphosphate-citrate lyase. Treatment of statin intolerant patients with bempedoic acid was ass…
Preview only. Read the full abstract at the source